المؤلفون: Heidari MM; Department of Biology, Yazd University, Yazd, Iran. heidarimm@yazd.ac.ir., Shirazi EA; Department of Biology, Yazd University, Yazd, Iran., Cheraghi SF; Department of Biology, Yazd University, Yazd, Iran., Shahshahani R; Department of Biology, Yazd University, Yazd, Iran., Rahnama T; Department of Biology, Yazd University, Yazd, Iran., Khatami M; Department of Biology, Yazd University, Yazd, Iran.

المصدر: Molecular biology reports [Mol Biol Rep] 2024 Jun 14; Vol. 51 (1), pp. 751. Date of Electronic Publication: 2024 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Single-Domain Antibodies*/genetics , Single-Domain Antibodies*/immunology , Mutagenesis, Site-Directed*/methods , Antigens, CD20*/immunology , Antigens, CD20*/genetics , Antigens, CD20*/metabolism , Rituximab*/pharmacology , Complementarity Determining Regions*/genetics , Complementarity Determining Regions*/immunology , Antibody Affinity*, Humans ; Cell Line, Tumor ; Animals

المؤلفون: Bobrowicz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Kusowska A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Krawczyk M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.; Doctoral School of Translational Medicine, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Zhylko A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Forcados C; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Slusarczyk A; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Department of General, Oncological and Functional Urology, Medical University of Warsaw, Warsaw, Poland., Barankiewicz J; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.; Faculty of Medicine, Lazarski University, Warsaw, Poland., Domagala J; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Kubacz M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Šmída M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic., Dostalova L; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Marhelava K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Fidyt K; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Pepek M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland., Baranowska I; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Szumera-Cieckiewicz A; Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Biobank, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Inderberg EM; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Wälchli S; Translational Research Unit, Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Granica M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Doctoral School, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Graczyk-Jarzynka A; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Majchrzak M; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland., Poreba M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland.; Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland., Gehlert CL; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany., Peipp M; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany., Firczuk M; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland., Prochorec-Sobieszek M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany., Winiarska M; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.; Laboratory of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Jun 04; Vol. 13 (1), pp. 2362454. Date of Electronic Publication: 2024 Jun 04 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20*/immunology , Antigens, CD20*/metabolism , Antigens, CD20*/genetics , Rituximab*/pharmacology , Rituximab*/therapeutic use , Tetraspanins*/genetics , Tetraspanins*/metabolism , Lymphoma, B-Cell*/immunology , Lymphoma, B-Cell*/therapy , Lymphoma, B-Cell*/genetics , Lymphoma, B-Cell*/drug therapy , Immunotherapy*/methods, Humans ; Cell Line, Tumor ; Antigens, Neoplasm/immunology ; Antigens, Neoplasm/genetics ; Drug Resistance, Neoplasm/drug effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Doxorubicin/pharmacology ; Doxorubicin/administration & dosage ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Vincristine/pharmacology ; Vincristine/therapeutic use ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Receptors, Chimeric Antigen/immunology ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/metabolism ; Gene Expression Regulation, Neoplastic

المؤلفون: Bender B; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Li CC; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Marchand M; Certara Strategic Consulting, Paris, France., Turner DC; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Li F; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Vadhavkar S; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Wang B; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Deng R; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Lu J; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Jin J; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Li C; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA., Yin S; Department of Product Development Oncology, Genentech Inc., South San Francisco, California, USA., Wei M; Department of Product Development Oncology, Genentech Inc., South San Francisco, California, USA., Chanu P; Department of Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.

المصدر: Clinical and translational science [Clin Transl Sci] 2024 Jun; Vol. 17 (6), pp. e13825.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20*/immunology , Antigens, CD20*/metabolism , Lymphoma, B-Cell*/drug therapy , Lymphoma, B-Cell*/immunology , Antibodies, Bispecific*/pharmacokinetics , Antibodies, Bispecific*/administration & dosage , Antibodies, Bispecific*/immunology, Humans ; Middle Aged ; Male ; Aged ; Female ; Adult ; Antibodies, Monoclonal, Humanized/pharmacokinetics ; Antibodies, Monoclonal, Humanized/administration & dosage ; Aged, 80 and over ; Models, Biological ; Antineoplastic Agents, Immunological/pharmacokinetics ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/therapeutic use ; Young Adult ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Rituximab/pharmacokinetics ; Rituximab/administration & dosage

المؤلفون: Bui JK; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Allergy and Infection Diseases, University of Washington, Seattle, WA, USA., Starke CE; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Poole NH; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Rust BJ; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA., Jerome KR; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Kiem HP; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Allergy and Infection Diseases, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: hkiem@fredhutch.org., Peterson CW; Stem Cell and Gene Therapy Program, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA. Electronic address: cwpeters@fredhutch.org.

المصدر: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 May 01; Vol. 32 (5), pp. 1238-1251. Date of Electronic Publication: 2024 Feb 27.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20*/metabolism , Antigens, CD20*/immunology , B-Lymphocytes*/immunology , B-Lymphocytes*/metabolism , Disease Models, Animal* , Simian Immunodeficiency Virus*/immunology , Immunotherapy, Adoptive*/methods , Simian Acquired Immunodeficiency Syndrome*/immunology , Simian Acquired Immunodeficiency Syndrome*/therapy , HIV Infections*/therapy , HIV Infections*/immunology , Receptors, Chimeric Antigen*/immunology , Receptors, Chimeric Antigen*/metabolism, Animals ; Humans ; T-Lymphocytes/immunology ; T-Lymphocytes/metabolism ; HIV-1/immunology ; Viral Load ; Macaca mulatta

المؤلفون: Schwake C; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Steinle J; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Thiel S; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Timmesfeld N; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Haben S; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Ayzenberg I; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Gold R; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany., Hellwig K; From the Department of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany.

المصدر: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 Jul; Vol. 11 (4), pp. e200264. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

مواضيع طبية MeSH: B-Lymphocytes*/immunology , B-Lymphocytes*/drug effects , Lactation*/immunology , Antigens, CD20*/immunology, Humans ; Female ; Pregnancy ; Infant, Newborn ; Retrospective Studies ; Male ; Adult ; Infant Health ; Prenatal Exposure Delayed Effects/immunology ; Prenatal Exposure Delayed Effects/chemically induced ; Antigens, CD19/immunology ; Lymphocyte Count ; Rituximab/adverse effects ; Rituximab/administration & dosage ; Rituximab/pharmacology ; Immunologic Factors/adverse effects ; Immunologic Factors/administration & dosage ; Immunologic Factors/pharmacology ; Infant

المؤلفون: El Mahdaoui S; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark. Electronic address: sahla.el.mahdaoui.01@regionh.dk., Hansen MM; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Hansen MB; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Hvalkof VH; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Søndergaard HB; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Mahler MR; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Romme Christensen J; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Sellebjerg F; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., von Essen MR; Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.

المصدر: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2024 Jul; Vol. 264, pp. 110262. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-7035 (Electronic) Linking ISSN: 15216616 NLM ISO Abbreviation: Clin Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Sclerosis, Relapsing-Remitting*/cerebrospinal fluid , Multiple Sclerosis, Relapsing-Remitting*/drug therapy , Multiple Sclerosis, Relapsing-Remitting*/immunology , Multiple Sclerosis, Relapsing-Remitting*/blood , Antigens, CD20*/immunology , T Follicular Helper Cells*/immunology, Humans ; Female ; Adult ; Male ; Middle Aged ; T-Lymphocytes, Helper-Inducer/immunology ; Rituximab/therapeutic use ; T-Lymphocyte Subsets/immunology

المؤلفون: Guan J; Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Lin W; Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Liu W; Department of Radiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Hui D; Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

المصدر: Neuropathology : official journal of the Japanese Society of Neuropathology [Neuropathology] 2024 Jun; Vol. 44 (3), pp. 222-229. Date of Electronic Publication: 2023 Nov 14.

نوع المنشور: Case Reports; Review; Journal Article

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9606526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1789 (Electronic) Linking ISSN: 09196544 NLM ISO Abbreviation: Neuropathology Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Extranodal NK-T-Cell*/pathology , Lymphoma, Extranodal NK-T-Cell*/metabolism , Antigens, CD20*/metabolism, Humans ; Female ; Adult ; Central Nervous System Neoplasms/pathology ; Central Nervous System Neoplasms/metabolism ; Brain Neoplasms/pathology ; Brain Neoplasms/metabolism

المؤلفون: Sam J; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Hofer T; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Kuettel C; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Claus C; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Thom J; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Herter S; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Georges G; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Korfi K; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Lechmann M; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Eigenmann MJ; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Marbach D; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Jamois C; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Lechner K; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Krishnan SM; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Gaillard B; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Marinho J; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Kronenberg S; Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland., Kunz L; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Wilson S; Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom., Briner S; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Gebhardt S; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Varol A; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Appelt B; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Nicolini V; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Speziale D; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Bez M; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Bommer E; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Eckmann J; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Hage C; Roche Innovation Center Munich, Roche Pharma Research and Early Development, Penzberg, Germany., Limani F; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Jenni S; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Schoenle A; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Le Clech M; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Vallier JP; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Colombetti S; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Bacac M; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Gasser S; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Klein C; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland., Umaña P; Roche Innovation Center Zurich, Roche Pharma Research and Early Development, Schlieren, Switzerland.

المصدر: Blood [Blood] 2024 May 23; Vol. 143 (21), pp. 2152-2165.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: CD28 Antigens*/immunology , CD28 Antigens*/agonists , Antibodies, Bispecific*/pharmacology , Antigens, CD19*/immunology , Antigens, CD20*/immunology , Immunotherapy*/methods, Humans ; Animals ; Mice ; T-Lymphocytes/immunology ; Xenograft Model Antitumor Assays ; Mice, Inbred NOD

المؤلفون: Martin de Frémont G; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Université Paris Cité, Hôpital Cochin, Paris, France gregoire.martin-de-fremont@aphp.fr., Chabrolles H; 3IHP-Infection Inflammation et Interaction Hôtes Pathogènes, Virology Department, National Reference Centre for Enteroviruses and Parechoviruses, Coordination Laboratory, CHU, Clermont-Ferrand, France.; LMGE UMR CNRS 6023, Team Epidemiology and Pathophysiology of Enterovirus Infection, Université Clermont Auvergne, Clermont-Ferrand, France., Mirand A; 3IHP-Infection Inflammation et Interaction Hôtes Pathogènes, Virology Department, National Reference Centre for Enteroviruses and Parechoviruses, Coordination Laboratory, CHU, Clermont-Ferrand, France.; LMGE UMR CNRS 6023, Team Epidemiology and Pathophysiology of Enterovirus Infection, Université Clermont Auvergne, Clermont-Ferrand, France., L'Honneur AS; Department of Virology, Hôpital Cochin, Paris, France.; Institut Cochin, CNRS 8104/INSERM U1016, Université Paris Cité, Paris, France., Mélé N; Department of Neurology, GHU Paris Psychatrie et Neurosciences, Saint Anne Hospital Centre, Paris, France.; INSERM 1266 FHU NeuroVasc, Université Paris Cité, Paris, France., Dunogue B; Hôpital Cochin, Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Université Paris Cité, Hôpital Cochin, Paris, France., Boutboul D; Department of Hematology, Université Paris Cité, Hôpital Cochin, Paris, France., Farhat M; Department of Internal Medicine, Université de Lille, CHU de Lille, Lille, France., Hachulla E; Department of Internal Medicine, Université de Lille, CHU de Lille, Lille, France., Lazrek M; Department of Virology, CHU de Lille, Lille, France., Rieu V; Department of Internal Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France., Mathian A; Department of Internal Medicine 2, Centre de référence pour le Lupus, Syndrome des anti-phospholipides et autres maladies auto-immunes rares, Institut E3M, Groupe Hospitalier La Pitié Salpêtrière-Charles Foix, Paris, France.; INSERM, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Paris, France., Chaussade H; Department of Internal Medicine, Université de Bordeaux, CHU Bordeaux GH Pellegrin, Bordeaux, France., Ruet A; Department of Neurology, Université de Bordeaux, CHU de Bordeaux, Bordeaux, France., Burrel S; Department of Virology, CHU de Bordeaux, Bordeaux, France.; UMR 5234, Fundamental Microbiology and Pathogenicity, CNRS, Université de Bordeaux, Bordeaux, France., Coury-Lucas F; Department of Rheumatology, Université Claude Bernard Lyon 1, CHU Lyon, Lyon, France., Schuffenecker I; Department of Virology, National Reference Centre for Enteroviruses and Parechoviruses, Associated Laboratory, Université Claude Bernard Lyon 1, CHU Lyon, Lyon, France., Lemaignen A; Department of Infectious Diseases, CHU de Tours, Tours, France., Stefic K; Department of Virology, CHU de Tours, Tours, France., le Besnerais M; Department of Internal Medicine, CHU de Rouen, Rouen, France., Carrette M; Department of Immunology, CHU de Rouen, Rouen, France., Mouthon L; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Université Paris Cité, Hôpital Cochin, Paris, France., Avettand-Fenoel V; Department of Virology, Hôpital Cochin, Paris, France.; Institut Cochin, CNRS 8104/INSERM U1016, Université Paris Cité, Paris, France., Terrier B; Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Université Paris Cité, Hôpital Cochin, Paris, France., Hadjadj J; Department of Internal Medicine, Sorbonne Université, Hôpital Saint-Antoine, Paris, France.

المصدر: RMD open [RMD Open] 2024 May 20; Vol. 10 (2). Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE

مواضيع طبية MeSH: Enterovirus Infections*/immunology , Enterovirus Infections*/diagnosis , Antibodies, Monoclonal*/therapeutic use , Antigens, CD20*/immunology, Humans ; Male ; Female ; Middle Aged ; Adult ; Meningoencephalitis/immunology ; Meningoencephalitis/virology ; Meningoencephalitis/etiology ; Meningoencephalitis/diagnosis ; Meningoencephalitis/drug therapy ; Aged ; Rituximab/therapeutic use ; B-Lymphocytes/immunology ; Agammaglobulinemia/immunology ; Agammaglobulinemia/complications ; Inflammation/immunology

المؤلفون: Pinho ACO; CNC-UC- Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.; CIBB -Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Department of Life Sciences, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal., Barbosa P; CNC-UC- Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.; CIBB -Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal., Pereira MJ; Department of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, Uppsala, Sweden., Paiva A; CIBB -Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Onco-biology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.; Instituto Politécnico de Coimbra, ESTESC-Coimbra Health School, Ciências Biomédicas Laboratoriais, Coimbra, Portugal., Carvalho E; CNC-UC- Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.; CIBB -Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal.; APDP-Portuguese Diabetes Association, Lisbon, Portugal., Laranjeira P; CNC-UC- Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.; CIBB -Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Flow Cytometry Unit, Clinical Pathology Department, Hospitais da Universidade de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Onco-biology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.

المصدر: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 May; Vol. 106 (3), pp. 171-180. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4957 (Electronic) Linking ISSN: 15524949 NLM ISO Abbreviation: Cytometry B Clin Cytom Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20*/immunology , Flow Cytometry*, Humans ; Male ; Female ; Adult ; Interferon-gamma ; Tumor Necrosis Factor-alpha ; Interleukin-17/blood ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/metabolism ; Lymphocyte Activation/immunology ; Middle Aged ; Immunologic Memory/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; Programmed Cell Death 1 Receptor/metabolism ; Programmed Cell Death 1 Receptor/immunology ; Cytokines/metabolism ; Memory T Cells/immunology ; Interleukin-2 Receptor alpha Subunit/immunology